Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

D-serine Antipsychotic Monotherapy for Treatment Refractory Schizophrenia

NCT00816894 is registered in ClinicalTrials.gov with Herzog Hospital as lead sponsor.

NCT NCT00816894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00816894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
D-serine Antipsychotic Monotherapy for Treatment Refractory Schizophrenia
Lead sponsor
Herzog Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
February 28, 2013
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia